Dually Crosslinked Supramolecular Hydrogel for Cancer Biomarker Sensing

ACS Appl Mater Interfaces. 2020 Aug 19;12(33):36873-36881. doi: 10.1021/acsami.0c08722. Epub 2020 Aug 6.

Abstract

Lysophosphatidic acid (LPA) as the biomarker of early stage ovarian cancer is essentially difficult to detect due to lack of target spots. A dually crosslinked supramolecular hydrogel (DCSH) was developed to achieve sensing of LPA, which acts as a competitive guest molecule triggering the responsive crosslinking of the DCSH. Through this strategy, the surface plasmon resonance combined with optical waveguide spectroscopy could be used to quantitatively detect LPA with a responsive range covering physiological conditions (in pure form as well as mimicking LPA plasma solution) with high selectivity and sensitivity. LPA efficiently immerses into the host molecule β-cyclodextrin (β-CD) up to a 1:2 ratio by the competitive interaction mechanism, confirmed by one-dimensional nuclear overhauser effect spectroscopy (1D NOESY), high-resolution mass spectrometry (HRMS), isothermal titration calorimetry (ITC), and computational simulation. Our method opens a new strategy to detect biomarkers without target spots and provides a platform for surface plasmon resonance (SPR)-based sensors measuring small molecules.

Keywords: SPR; dually crosslinked supramolecular hydrogel; lysophosphatidic acid; sensor.

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Biosensing Techniques
  • Computer Simulation
  • Cross-Linking Reagents / chemistry*
  • Female
  • Humans
  • Hydrogels / chemistry*
  • Limit of Detection
  • Lysophospholipids / analysis*
  • Molecular Conformation
  • Ovarian Neoplasms / diagnosis*
  • Surface Plasmon Resonance
  • beta-Cyclodextrins / chemistry

Substances

  • Biomarkers, Tumor
  • Cross-Linking Reagents
  • Hydrogels
  • Lysophospholipids
  • beta-Cyclodextrins
  • betadex
  • lysophosphatidic acid